Related Experiment Video
Updated: Oct 9, 2025

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
Non-Coding RNA Networks in Pulmonary Hypertension.
Hongbin Zang1, Qiongyu Zhang2, Xiaodong Li1
1Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, China.
Non-coding RNAs (ncRNAs) like miRNAs, lncRNAs, and circRNAs play roles in pulmonary hypertension (PH). This review details their functions and regulatory networks, offering insights for clinical applications.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Background:
- Non-coding RNAs (ncRNAs) are crucial regulators of cellular processes.
- Specific roles of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in pulmonary hypertension (PH) are not fully understood.
- Understanding ncRNA functions in PH is vital for developing new therapeutic strategies.
Purpose of the Study:
- To systematically review and synthesize current knowledge on the functions of ncRNAs in pulmonary hypertension.
- To construct regulatory networks involving ncRNAs and their interacting molecules in PH.
- To highlight the potential clinical applications of ncRNAs in PH management.
Main Methods:
- Comprehensive literature search and manual review of studies on ncRNAs in PH.
- Systematic collection of data on ncRNA functions, experimental methods, and regulatory interactions.
- Construction of regulatory networks integrating ncRNAs (lncRNAs, circRNAs, miRNAs) and messenger RNAs (mRNAs) from relevant cell types.
Main Results:
- Identified and reviewed studies detailing the roles of 14 lncRNAs, 1 circRNA, and 74 miRNAs in PH.
- Constructed regulatory networks incorporating 110 mRNAs, providing a systems-level view of ncRNA involvement.
- Highlighted the complex regulatory mechanisms orchestrated by ncRNAs in pulmonary arterial smooth muscle cells, pulmonary artery endothelial cells, and pulmonary artery fibroblasts.
Conclusions:
- ncRNAs significantly contribute to the pathogenesis of pulmonary hypertension through intricate regulatory networks.
- The synthesized knowledge and constructed networks offer a deeper understanding of ncRNA roles in PH.
- These findings underscore the therapeutic potential of targeting ncRNAs for clinical interventions in PH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
lncRNA - Long Non-coding RNAs
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Regulation of Angiogenesis and Blood Supply
Types of RNA
RNA Performs Diverse...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

